ASO Visual Abstract: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer

Annals of Surgical Oncology ◽

10.1245/s10434-021-11216-2 ◽

2022 ◽

Author(s):

Alexander Ring ◽

Daniel Campo ◽

Tania B. Porras ◽

Pushpinder Kaur ◽

Victoria A. Forte ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Tumor Cell ◽

Metastatic Breast ◽

Circulating Tumor Cell

Download Full-text

Faculty Opinions recommendation of Mutation Analysis of Cell-Free DNA and Single Circulating Tumor Cells in Metastatic Breast Cancer Patients with High Circulating Tumor Cell Counts.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726443839.793535260 ◽

2017 ◽

Cited By ~ 1

Author(s):

Wafik El-Deiry

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Tumor Cell ◽

Cancer Patients ◽

Tumor Cells ◽

Metastatic Breast ◽

Circulating Tumor Cell ◽

Breast Cancer Patients ◽

Cell Counts ◽

Free Dna

Download Full-text

Abstract GS4-08: Clinical utility of repeated circulating tumor cell (CTC) enumeration as early treatment monitoring tool in metastatic breast cancer (MBC) - a global pooled analysis with individual patient data

10.1158/1538-7445.sabcs20-gs4-08 ◽

2021 ◽

Author(s):

Wolfgang J Janni ◽

Tracy C. Yab ◽

Daniel F. Hayes ◽

Massimo Cristofanilli ◽

Francois-Clement Bidard ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Tumor Cell ◽

Clinical Utility ◽

Individual Patient Data ◽

Metastatic Breast ◽

Circulating Tumor Cell ◽

Pooled Analysis ◽

Treatment Monitoring ◽

Monitoring Tool

Download Full-text

Abstract S5-07: SWOG S0500 – A randomized phase III trial to test the strategy of changing therapy versus maintaining therapy for metastatic breast cancer patients who have elevated circulating tumor cell (CTC) levels at first follow-up assessment

10.1158/0008-5472.sabcs13-s5-07 ◽

2013 ◽

Cited By ~ 5

Author(s):

JB Smerage ◽

WE Barlow ◽

DF Hayes ◽

EP Winer ◽

B Leyland-Jones ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Tumor Cell ◽

Cancer Patients ◽

Metastatic Breast ◽

Circulating Tumor Cell ◽

Phase Iii ◽

Breast Cancer Patients ◽

Phase Iii Trial

Download Full-text

Abstract 1351: A novel application of DEPArrayTMNxT System to isolate circulating tumor cell (CTC)-clusters from patients with metastatic breast cancer (MBC)

10.1158/1538-7445.am2019-1351 ◽

2019 ◽

Author(s):

Qiang Zhang ◽

Lorenzo Gerratana ◽

Ami N. Shah ◽

Andrew A. Davis ◽

Lisa Flaum ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Tumor Cell ◽

Metastatic Breast ◽

Circulating Tumor Cell

Download Full-text

Abstract 3119: Comparison of circulating tumor cell (CTC) derived DNA and circulating cell-free DNA (cfDNA) from simultaneous blood sampling of patients with metastatic breast cancer (MBC)

10.1158/1538-7445.am2020-3119 ◽

2020 ◽

Author(s):

Minetta C. Liu ◽

Karthik V. Giridhar ◽

Roberto A. Leon Ferre ◽

Jamie L. Carroll ◽

Matthew P. Goetz ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Tumor Cell ◽

Metastatic Breast ◽

Circulating Tumor Cell ◽

Blood Sampling ◽

Cell Free Dna ◽

Free Dna ◽

Circulating Cell Free Dna

Download Full-text

Abstract P3-01-10: Associations between plasma Interleukin 2 (IL-2) and HER2 expression in circulating tumor cell (CTC) and MYC alterations in circulation tumor DNA (ctDNA) open a new insight on immune microenvironment for patients with metastatic breast cancer (MBC)

10.1158/1538-7445.sabcs18-p3-01-10 ◽

2019 ◽

Author(s):

Q Zhang ◽

L Gerratana ◽

Y Zhang ◽

L Flaum ◽

A Shah ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Tumor Cell ◽

Interleukin 2 ◽

Metastatic Breast ◽

Circulating Tumor Cell ◽

Her2 Expression ◽

Immune Microenvironment ◽

Tumor Dna

Download Full-text

Abstract P3-01-05: Circulating tumor cell detection predicts early recurrence in patients with non-metastatic breast cancer

10.1158/1538-7445.sabcs18-p3-01-05 ◽

2019 ◽

Author(s):

C Hall ◽

S Meas ◽

J Bowman Bauldry ◽

H Kuerer ◽

A Lucci

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Tumor Cell ◽

Metastatic Breast ◽

Circulating Tumor Cell ◽

Early Recurrence ◽

Cell Detection ◽

Tumor Cell Detection

Download Full-text

Monitoring circulating tumor cell (CTC) levels to predict rapid progression in metastatic breast cancer (MBC): A prospective, multi-institutional tria

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.509 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 509-509 ◽

Cited By ~ 4

Author(s):

D. F. Hayes ◽

M. Cristofanilli ◽

G. T. Budd ◽

M. Ellis ◽

A. Stopeck ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Tumor Cell ◽

Metastatic Breast ◽

Circulating Tumor Cell ◽

Rapid Progression

Download Full-text

Clinical validity of circulating tumor cell (CTC) enumeration in 841 subjects with metastatic breast cancer (MBC).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.10592 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 10592-10592 ◽

Cited By ~ 6

Author(s):

M. C. Liu ◽

M. Mego ◽

S. Nakamura ◽

F. Nole ◽

J. Pierga ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Tumor Cell ◽

Metastatic Breast ◽

Circulating Tumor Cell ◽

Clinical Validity

Download Full-text

Correlation of circulating tumor cell phenotypes based on epithelial-mesenchymal transition with prognosis in first-line chemotherapy of HER2-negative metastatic breast cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e24039 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e24039-e24039

Author(s):

Xiuwen Guan ◽

Fei Ma ◽

Chunxiao Li ◽

Shiyang Wu ◽

Shangying Hu ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Tumor Cell ◽

Epithelial Mesenchymal Transition ◽

Metastatic Breast ◽

Circulating Tumor Cell ◽

First Line ◽

Mesenchymal Transition ◽

Cell Phenotypes ◽

Line Chemotherapy

Download Full-text